Chronic Kidney Disease and Healthy Adults
Conditions
Interventions
None listed
Sponsors
Okayama University
Kurume University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who visit Iyasaka Kidney Clinic as outpatients or for health check-ups between the date of approval by the head of the research institution and the end of March 2029. 2.Aged 40 years or older at the time of obtaining informed consent (No upper age limit is set. This is to evaluate age-related muscle mass loss and muscle weakness, which are the pathology of sarcopenia.) 3.Regardless of gender. 4.Patients who are receiving stable treatment. 5.Patients who can provide written informed consent for study participation of their own free will.
Exclusion criteria
Exclusion criteria: 1.Female patients who are pregnant, breastfeeding, or possibly pregnant. 2.Patients with severe cardiac, hepatic, or biliary tract diseases (left ventricular ejection fraction of 40% or less, AST of 150 IU or higher, or ALT of 150 IU or higher). 3.Patients with concurrent malignant tumors or inflammatory diseases. 4.Other patients deemed unsuitable for the study by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of sarcopenia, skeletal muscle mass, grip strength, vascular function indices, and nutrient intake based on a food frequency questionnaire(Timepoint: at study enrollment) | — |
Countries
Japan
Contacts
Public ContactMiyuki Hisanari
Okayama University Faculty of Education
Outcome results
None listed